Supriya Lifescience Limited (NSE:SUPRIYA)
897.50
-19.75 (-2.15%)
Jun 3, 2026, 12:31 PM IST
Supriya Lifescience Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Supriya Lifescience stock has a consensus rating of "Buy" and an average price target of ₹940.00. The average 1-year stock price forecast is 4.74% higher than the current stock price, while the lowest is ₹850.00 (-5.29%) and the highest is ₹1,030 (+14.76%).
Price Target: ₹940.00 (+4.74%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Supriya Lifescience stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Nov '25 | Jan '26 | Feb '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 1 | 1 | 1 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
9.94B
from 8.28B
Increased by 20.01%
Revenue Next Year
12.42B
from 9.94B
Increased by 24.99%
EPS This Year
29.90
from 25.98
Increased by 15.09%
EPS Next Year
4.10
from 29.90
Decreased by -86.29%
Financial currency is INR.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 9.9B | ||
| Avg | 9.9B | ||
| Low | 9.9B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 20.0% | ||
| Avg | 20.0% | ||
| Low | 20.0% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 29.90 | ||
| Avg | 29.90 | ||
| Low | 29.90 |
EPS Growth
| EPS Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 15.1% | ||
| Avg | 15.1% | ||
| Low | 15.1% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by S&P Global Market Intelligence. The data is sourced from Wall Street analysts. Data sources.